Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Over the last 12 months, insiders at Viking Therapeutics, Inc. have bought $0 and sold $40.3M worth of Viking Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Viking Therapeutics, Inc. have bought $224,995 and sold $21.4M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 90,000 shares for transaction amount of $222,390 was made by FOEHR MATTHEW W () on 2022‑05‑02.
2024-05-03 | Sale | ZANTE GREG | Chief Financial Officer | 66,756 0.0587% | $74.69 | $4.99M | -19.14% | |
2024-05-01 | Sale | Mancini Marianna | Chief Operating Officer | 281,425 0.2627% | $78.66 | $22.14M | -18.51% | |
2024-02-09 | Sale | Lian Brian | President & CEO | 45,000 0.0564% | $29.90 | $1.35M | +119.10% | |
2024-02-08 | Sale | Lian Brian | President & CEO | 269,079 0.3033% | $26.87 | $7.23M | +131.83% | |
2024-02-08 | Sale | Rouan Sarah Kathryn | director | 25,000 0.0294% | $28.05 | $701,250 | +131.83% | |
2024-01-31 | Sale | Lian Brian | President & CEO | 85,000 0.0881% | $24.71 | $2.1M | +170.38% | |
2024-01-30 | Sale | Lian Brian | President & CEO | 35,000 0.0352% | $23.95 | $838,250 | +172.72% | |
2024-01-19 | Sale | Rouan Sarah Kathryn | director | 30,000 0.0321% | $23.05 | $691,500 | +201.12% | |
2024-01-04 | Sale | ZANTE GREG | Chief Financial Officer | 15,000 0.0144% | $17.90 | $268,500 | +240.47% | |
2023-05-16 | Sale | MACARTNEY LAWSON | director | 16,000 0.0199% | $24.00 | $384,000 | -23.11% | |
2023-05-16 | Sale | Rowland Charles A Jr | director | 40,000 0.0518% | $25.00 | $1M | -23.11% | |
2023-05-01 | Sale | Lian Brian | President & CEO | 45,000 0.0583% | $22.45 | $1.01M | -14.33% | |
2023-04-24 | Sale | MACARTNEY LAWSON | director | 16,000 0.0211% | $22.00 | $352,061 | -11.16% | |
2023-04-19 | Sale | Lian Brian | President & CEO | 35,000 0.045% | $21.45 | $750,750 | -10.91% | |
2023-04-17 | Sale | Lian Brian | President & CEO | 155,000 0.2061% | $20.45 | $3.17M | -3.46% | |
2023-04-17 | Sale | Mancini Marianna | Chief Operating Officer | 12,500 0.0163% | $20.00 | $250,000 | -3.46% | |
2023-04-17 | Sale | ZANTE GREG | Chief Financial Officer | 7,500 0.0098% | $20.00 | $150,000 | -3.46% | |
2023-04-17 | Sale | MACARTNEY LAWSON | director | 20,786 0.027% | $20.00 | $415,720 | -3.46% | |
2023-04-13 | Sale | Lian Brian | President & CEO | 79,336 0.1003% | $18.45 | $1.46M | +0.46% | |
2023-04-12 | Sale | ZANTE GREG | Chief Financial Officer | 41,544 0.0538% | $18.00 | $747,792 | +5.25% |
Lian Brian | President & CEO | 2139882 2.1295% | $47.39 | 0 | 11 | |
Mancini Marianna | Chief Operating Officer | 348508 0.2864% | $47.39 | 0 | 4 | |
ZANTE GREG | Chief Financial Officer | 174854 0.1799% | $47.39 | 0 | 7 | |
Rouan Sarah Kathryn | director | 0 0% | $47.39 | 0 | 2 | |
LIGAND PHARMACEUTICALS INC | 10 percent owner | 5819383 5.7911% | $47.39 | 0 | 3 | |
FOEHR MATTHEW W | 111250 0.1107% | $47.39 | 5 | 1 | +1.66% | |
MORNEAU MICHAEL | VP, Finance and Administration | 94035 0.0936% | $47.39 | 0 | 1 | |
MACARTNEY LAWSON | director | 47965 0.0477% | $47.39 | 1 | 3 | +92.12% |
Rowland Charles A Jr | director | 30000 0.0299% | $47.39 | 1 | 1 | +92.12% |
SINGLETON J MATTHEW | director | 9500 0.0095% | $47.39 | 1 | 0 | <0.0001% |
Webster Stephen W | director | 8000 0.008% | $47.39 | 1 | 0 | +92.12% |
Fidelity Investments | $1.34B | 14.83 | 16.35M | +8.95% | +$110.12M | 0.09 | |
BlackRock | $678.48M | 7.5 | 8.27M | +8.79% | +$54.8M | 0.02 | |
The Vanguard Group | $638.43M | 7.06 | 7.79M | +44.66% | +$197.11M | 0.01 | |
Avoro Capital Advisors Llc | $294.38M | 3.26 | 3.59M | New | +$294.38M | 3.53 | |
State Street | $272.78M | 3.02 | 3.33M | -41.98% | -$197.33M | 0.01 | |
Geode Capital Management | $190.82M | 2.11 | 2.33M | +9.32% | +$16.27M | 0.02 | |
AllianceBernstein | $127.99M | 1.42 | 1.56M | -57.52% | -$173.27M | 0.05 | |
Viking Global Investors | $89.79M | 0.99 | 1.09M | -78.72% | -$332.11M | 0.03 | |
Voya Investment Management LLC | $87.62M | 0.97 | 1.07M | +2,679.91% | +$84.47M | 0.1 | |
JPMorgan Chase | $85.29M | 0.94 | 1.04M | +83.26% | +$38.75M | 0.01 | |
Morgan Stanley | $81.95M | 0.91 | 999,371 | -33.95% | -$42.13M | 0.01 | |
Perceptive Advisors | $81.52M | 0.9 | 994,098 | New | +$81.52M | 0.05 | |
Perpetual Limited | $78.59M | 0.87 | 958,368 | New | +$78.59M | 0.78 | |
Northern Trust | $78.13M | 0.86 | 952,857 | +3.98% | +$2.99M | 0.01 | |
Citadel Advisors LLC | $73.94M | 0.82 | 901,749 | +1,160.01% | +$68.07M | 0.05 | |
Charles Schwab | $68.8M | 0.76 | 838,984 | +8.16% | +$5.19M | 0.02 | |
American Century Investments | $68.23M | 0.76 | 832,132 | -62.58% | -$114.12M | 0.04 | |
Braidwell Lp | $58.47M | 0.65 | 713,100 | New | +$58.47M | 3.3 | |
Invesco | $57.07M | 0.63 | 695,934 | +405.9% | +$45.79M | 0.01 | |
Hood River Capital Management LLC | $55.1M | 0.61 | 671,928 | New | +$55.1M | 1.23 | |
Westfield Capital Management Co Lp | $54.29M | 0.6 | 662,131 | New | +$54.29M | 0.29 | |
Goldman Sachs | $52.66M | 0.58 | 642,196 | -42.66% | -$39.17M | 0.01 | |
ClearBridge Investments | $48.97M | 0.54 | 597,189 | New | +$48.97M | 0.04 | |
Bamco | $40.45M | 0.45 | 493,259 | +59.08% | +$15.02M | 0.11 | |
Macquarie Group | $39.11M | 0.43 | 476,935 | +44.48% | +$12.04M | 0.03 | |
Alger | $38.31M | 0.42 | 467,216 | New | +$38.31M | 0.19 | |
Deerfield Management | $38.01M | 0.42 | 463,501 | -63.76% | -$66.87M | 0.74 | |
Nuveen | $37.81M | 0.42 | 461,082 | +72.29% | +$15.87M | 0.01 | |
Integral Health Asset Management Llc | $36.9M | 0.41 | 450,000 | -10% | -$4.1M | 3.66 | |
Ameriprise Financial | $36.84M | 0.41 | 450,414 | +484.64% | +$30.54M | 0.01 | |
Artia Global Partners Lp | $35.55M | 0.39 | 433,580 | +13.04% | +$4.1M | 8.79 | |
Bank of America | $33.82M | 0.37 | 412,415 | -46.48% | -$29.37M | <0.01 | |
Millennium Management LLC | $32.56M | 0.36 | 397,089 | -1.43% | -$472,894.00 | 0.02 | |
Marshall Wace | $30.48M | 0.34 | 371,686 | +261.37% | +$22.04M | 0.04 | |
Ubs Asset Management Americas Inc | $29.16M | 0.32 | 355,588 | -25.16% | -$9.8M | 0.01 | |
683 Capital Management Llc | $29.11M | 0.32 | 355,000 | -42.74% | -$21.73M | 3.27 | |
Lord Abbett | $28.62M | 0.32 | 349,074 | New | +$28.62M | 0.1 | |
BNY Mellon | $28.58M | 0.32 | 348,493 | +3.19% | +$884,370.40 | 0.01 | |
Jane Street Capital | $28.46M | 0.32 | 347,088 | -0.9% | -$258,464.00 | 0.03 | |
Russell Investments Group Ltd | $28.28M | 0.31 | 344,825 | +34.37% | +$7.23M | 0.04 | |
Franklin Templeton Investments | $27.92M | 0.31 | 340,511 | +2,161.33% | +$26.69M | 0.01 | |
Granahan Investment Management | $26.15M | 0.29 | 318,893 | New | +$26.15M | 0.92 | |
Boone Capital Management Llc | $25.46M | 0.28 | 310,462 | New | +$25.46M | 5.15 | |
Emerald Advisers, Inc. | $25.5M | 0.28 | 311,007 | New | +$25.5M | 1.04 | |
Boxer Capital, LLC | $24.6M | 0.27 | 300,000 | New | +$24.6M | 1.23 | |
Blair William Co Il | $24.54M | 0.27 | 299,235 | +412.63% | +$19.75M | 0.08 | |
Massachusetts Financial Services Co Ma | $24.07M | 0.27 | 293,585 | -55.73% | -$30.3M | 0.01 | |
Ensign Peak Advisors Inc | $23.47M | 0.26 | 286,160 | -0.73% | -$173,102.00 | 0.04 | |
Susquehanna International Group | $23.45M | 0.26 | 285,917 | +91.53% | +$11.2M | 0.03 | |
HERITAGE ASSET MANAGEMENT INC | $22.33M | 0.26 | 280,848 | +7.28% | +$1.52M | 0.12 |